These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6399414)

  • 1. [Analysis of the daily insulin requirements as determined by a biostator (artificial pancreas) in patients with insulin-dependent diabetes mellitus].
    Djurić DS; Mićić JV; Micić D; Brkić V; Nesović M; Djordjević P; Dragasević M
    Srp Arh Celok Lek; 1983; 111(9-10):1351-60. PubMed ID: 6399414
    [No Abstract]   [Full Text] [Related]  

  • 2. [Use of the biostator (artificial pancreas) in the treatment of patients with diabetes mellitus].
    Spesivtseva VG; Mamaeva GG; Belokrinitskiĭ DV; Starosel'tseva LK; Turova EA
    Klin Med (Mosk); 1984 Oct; 62(10):55-60. PubMed ID: 6513454
    [No Abstract]   [Full Text] [Related]  

  • 3. Improvement of artificial endocrine pancreas (Biostator; GCIIS) performance combining feedback controlled insulin administration with a pre-programmed insulin infusion.
    Calabrese G; Bueti A; Zega G; Giombolini A; Bellomo G; Antonella MA; Massi-Benedetti M; Brunetti P
    Horm Metab Res; 1982 Oct; 14(10):505-7. PubMed ID: 6757081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Insulin needs of insulin-dependent diabetics during biostator control and subcutaneous use of insulin].
    Petkova M; Khristov V; Tsanev A
    Vutr Boles; 1990; 29(1):74-7. PubMed ID: 2204207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of the insulin requirements with an artificial pancreas in the pregnant woman with gestational insulin-dependent diabetes (type I)].
    Fernández I; Gutiérrez A; Rodríguez MA; Costa CJ; Sánchez Ramos J; Durán García S
    Med Clin (Barc); 1989 Jun; 93(3):88-92. PubMed ID: 2677543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of diabetes mellitus with an artificial pancreas].
    Bargero G; Capra Marzani M; Fasano M; Guazzo G; Minoglio S; Rosso A
    Minerva Med; 1988 Apr; 79(4):253-4. PubMed ID: 3368103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Use of the artificial endocrine pancreas in the clinic].
    Tsanev A; Zlateva S; Khristov V; Petkova M
    Vutr Boles; 1985; 24(6):107-11. PubMed ID: 4095982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of the insulin requirements with an artificial pancreas in gestational diabetes].
    Fernández I; Rodríguez MA; Gutiérrez A; Costa CJ; Sánchez Ramos J; Durán García S
    Med Clin (Barc); 1989 Jun; 93(4):129-33. PubMed ID: 2677545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The artificial pancreas in insulin-dependent diabetes].
    Lysy J; Globus M; Corcos A; Chowers I
    Harefuah; 1984 May; 106(9):413-4. PubMed ID: 6381260
    [No Abstract]   [Full Text] [Related]  

  • 10. Diurnal pattern of insulin requirements in insulin-dependent diabetics.
    Mathiesen ER; Rubin P; Sandahl Christiansen J; Aaby Svendsen P; Lauritzen T; Deckert T
    Scand J Clin Lab Invest; 1982 Feb; 42(1):63-8. PubMed ID: 6753093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapeutic hyperinsulinism induced by the use of continuous insulin infusion pumps and the artificial pancreas in diabetic patients].
    Bergua M; Levy I; Casamitjana R; Figuerola D
    Med Clin (Barc); 1983 Sep; 81(6):243-5. PubMed ID: 6358714
    [No Abstract]   [Full Text] [Related]  

  • 12. [Remission of recently-appearing insulin-dependent diabetes mellitus: value of continuous infusion of insulin].
    Arlot S; Lalau JD; Mesmacque A; Quichaud J
    LARC Med; 1984 Oct; 4(8):475-8. PubMed ID: 6513704
    [No Abstract]   [Full Text] [Related]  

  • 13. Reduction of post-prandial insulin needs by pectin as assessed by the artificial pancreas in insulin-dependent diabetics.
    Poynard T; Slama G; Tchobroutsky G
    Diabete Metab; 1982 Sep; 8(3):187-9. PubMed ID: 6754491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid decrease of platelet aggregation (ADP--and collagen--induced) and of platelet circulating aggregates by the artificial pancreas in insulin-dependent diabetics.
    Coppola L; Misso L; Giugliano D; Torella R; Passariello N; Tirelli A
    Diabete Metab; 1984 Jan; 10(1):31-5. PubMed ID: 6724099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Implantable fixed continuous flow pumps in type I diabetes (insulin-dependent diabetes)].
    Irsigler K; Kritz H; Najemnik C; Hagmüller G; Lovett R
    Journ Annu Diabetol Hotel Dieu; 1983; ():65-78. PubMed ID: 6645142
    [No Abstract]   [Full Text] [Related]  

  • 16. Feasibility and efficacy of long-term treatment by continuous subcutaneous insulin infusion (CSII) in insulin-dependent diabetes.
    Van Ballegooie E; Reitsma WD; Sluiter WJ; Doorenbos H
    Neth J Med; 1984; 27(5):185-92. PubMed ID: 6427640
    [No Abstract]   [Full Text] [Related]  

  • 17. [Various biohumoral parameters (blood triglycerides, blood cholesterol, blood uric acid, blood electrolytes) after automatic control by an artificial pancreas in subjects with type I diabetes mellitus].
    Sinagra D; Amato MP; Cangemi C; La Sala MS
    Boll Soc Ital Biol Sper; 1984 Sep; 60(9):1691-5. PubMed ID: 6525287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use of the endocrine artificial pancreas (GCIIS; Biostator) in heart surgery].
    Calabrese G; Bueti A; Zega G; Bellomo G; Antonella MA; Giombolini A; Tardioli F; Massi-Benedetti M; Palminiello A
    Minerva Med; 1982 Dec; 73(49-50):3509-14. PubMed ID: 7155400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Use of the Biostator in optimizing insulin treatment (preliminary communication)].
    Kábrt J; Masek Z; Páv J
    Vnitr Lek; 1985 Sep; 31(9):870-6. PubMed ID: 4049764
    [No Abstract]   [Full Text] [Related]  

  • 20. [Evaluation after one year of portable insulin infusion pumps].
    Solal PC; Bertoglio J; Cupelli C
    Soins; 2004 Sep; (688):21-2. PubMed ID: 15515843
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.